Entinostat in combination with nivolumab in metastatic pancreatic ductal adenocarcinoma: a phase 2 clinical trialMarina Baretti(Johns Hopkins University), Nilofer S. Azad(Bloomberg (United States))Nature CommunicationsNovember 12, 202410.1038/s41467-024-52528-7Cited by 35SaveCiteExport RISWatch citationsRelated PapersA phase I trial of vertical inhibition of IGF signalling using cixutumumab, an anti-IGF-1R antibody, and selumetinib, an MEK 1/2 inhibitor, in advanced solid tumours|British Journal of Cancer|2014|37